Breast Cancer Breakthroughs we de mek pɔsin gɛt kansa

We wi yɛri di wɔd "kansa," wi ɔl kin kray smɔl, nɔto so? Ɛspɛshali we wi yɛri di wɔd brɔst kansa, uman dɛn na wi kɔntri kin fred bad bad wan. Bɔt nɔ fred. Mɛdikal sayɛns de go bifo ɛvride. Naw dɛn dɔn kam wit nyu we dɛn na di wɔl fɔ no bɔt bɔdi kansa kwik ɛn fɔ trit am fayn fayn wan. So tide, lɛ wi tɔk bɔt dɛn nyu we dɛn ya we gɛt prɔmis. Fɔ no dɛn tin ya go rili impɔtant fɔ yu ɛn di wan dɛn we yu lɛk.

Di laytst skan we fɔ no kansa

Wi kin du mamogram ɛn ɔltra saund fɔ chɛk if wi gɛt kansa na wi bɔdi. Sɔntɛnde, dɔktɔ dɛn kin se bak fɔ mek dɛn du MRI skan. Bɔt naw, di wan dɛn we de stɔdi bɔt dis de luk fɔ mɔ advans, mɔ kɔrɛkt skan dɛn.

Fɔ tɔk am simpul wan, dɛn tin ya na ay-tek, prɛsis we dɛn fɔ no di kansa sɛl dɛn.

• Optical Imaging: Dis min se yu fɔ shayn wan spɛshal layt bim tru di bɔdi. Di tɛst de mɛzhɔ di layt we de bounce bak ɔ travul tru di tisu. Naw dɛn de du risach fɔ si if dɛn kin jɔyn dis we wit MRI ɔ 3D mammogram fɔ no mɔ bɔt kansa.
• Molecular Breast Imaging (MBI): Na dis say sɔntin we rili wɔndaful kin apin. sכm sכm sכm redioaktiv mεdisin (tracer) dεn de injεkt insay di bכdi tru wan vein. Dis mεdisin de go stret to di brεst kεnsar sεl dεm εn stik to dεm. Dɔn, we yu luk am wit spɛshal kamɛra, yu go si usay di kansa sɛl dɛn de. Naw dɛn de luk if dɛn kin yuz dis we fɔ du dis tɛst apat frɔm wan mamogram fɔ uman dɛn we gɛt dense brɔst ɛn fɔ chɛk mɔ di lump dɛn we dɛn kin tink se dɛn kin si pan mammogram.
• Positron Emission Mammography (PEM): Dis lεk MBI, bכt i de yuz wan redioaktiv sכbstans we de atak wan shuga patikyula fכ no di kεnsar sεl dεm. Dɛn kin yuz dis we we dɛn nɔ ebul fɔ du MRI.
• Electrical Impedance Tomography (EIT): di brεst kεnsar sεl dεm de kכndukt ilektrikal difrεnt frכm di nכmal sεl dεm. Yu nɔ tink se dat na wɔndaful tin? Dis tɛst de luk fɔ da difrɛns de. I de mɛzhɔ di difrɛns bay we i de sɛn wan rili smɔl ilɛktrik kɔrɛnt tru smɔl smɔl ilɛktrɔd dɛn we dɛn put na di skin.

Atikul Intɛlijɛns (AI) ɛn Mamogram Tɛst

Yu no se trade, na wan dɔktɔ we de mɛn di raydiɔlɔji nɔmɔ go no if di mammogram nɔ gɛt kansa bay di tin dɛn we dɛn dɔn du we dɛn tek di mammogram? Bɔt mɔtalman kin mek mistek. Stɔdi dɔn sho se lɛk af pan di pipul dɛn we kin gɛt mammogram ɛvri ia fɔ 10 ia go gɛt lay lay pɔsitiv , we min se dɛn nɔ gɛt kansa, at le wan tɛm na dɛn layf. Ɛn bitwin 10% ɛn 30% go gɛt lay lay nɛgitiv , we min se dɛn nɔ gɛt kansa.

Naw, dɛn de yuz AI softwe fɔ ɛp dɔktɔ dɛn. Dis AI kin stɔdi bɔku bɔku mamogram dɛn ɛn no ivin di smɔl smɔl chenj dɛn we mɔtalman yay kin mis. Bɔt dis nɔ min se AI kin du di dɔktɔ in wok. Wit di teknɔlɔji we de naw, AI nɔ go ebul fɔ tek ples fɔ dɔktɔ. Di bɛst tin na dat, we dɛn jɔyn di ɛkspiriɛns we dɔktɔ gɛt ɛn di shap shap we aw AI de wach, dɛn kin no kansa kɔrɛkt wan ɛn kwik kwik wan .

Tɛrapi we dɛn de tɔk bɔt

Trade, dɛn bin de trit kansa wit kemotɛrapi. Kimotɛrapi na tritmɛnt we de afɛkt ɔl di sɛl dɛn we de sheb kwik kwik wan na di bɔdi. Dis min se i nɔ de afɛkt di kansa sɛl dɛn nɔmɔ, bɔt i de afɛkt di sɛl dɛn we gɛt wɛlbɔdi lɛk di ia sɛl dɛn ɛn di blɔd sɛl dɛn. Dis na di rizin fɔ di sayd ɛfɛkt dɛn we de bɔku.

Bɔt naw wan nyu tritmɛnt de we dɛn kɔl `(Targeted Therapy)`. Dis na sɔntin we rili spɛshal. sכm brεst kεnsar sεl dεm gεt spεshal protin we dεn kכl `HER2` na dεn sεf insay bכku bכku wan. tεrapi we dεn tכk bכt de כnli fכn di kεnsar sεl dεm we gεt da `HER2` protin de εn atak dεm. Dis kin mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl bɛtɛ.

Bɔku kayn tritmɛnt dɛn de we dɛn kin yuz fɔ mɛn pipul dɛn we dɛn kin tɔk to pipul dɛn tide. `Trastuzumab (Herceptin)` ɛn `Pertuzumab (Perjeta)` na jɔs sɔm pan dɛn. Yu dɔktɔ go disayd us tritmɛnt go fayn fɔ yu.

‘Liquid Biopsy’: I de no kansa wit wan drop pan blɔd

We wi tink bɔt bayɔpsi, wi kin tink bɔt fɔ kɔt wan smɔl pat pan di tisu frɔm wan say we wi kin sɔprayz ɛn chɛk am. Bɔt imajin aw i go izi if wi ebul fɔ no bɔt kansa bay wan simpul blɔd tɛst? Na dat dɛn kɔl ``Liquid Biopsy.''

We yu gɛt kansa, smɔl smɔl DNA we dɔn brok kin gɛda na yu blɔd. dis dεn kכl am ``sεkyulεt tכmכro DNA''. Wan likwid bayɔpsi de luk fɔ dɛn pat dɛn de pan kansa DNA na blɔd sɛmpul. Dis gɛt bɔku bɛnifit dɛn:

• Dɛn kin no di chenj (muteshɔn) pan kansa kwik kwik wan we dɛn de trit am .
• Fɔ du dat, dɔktɔ dɛn kin chenj di we aw dɛn de trit dɛn kwik kwik wan ɛn gi dɛn tritmɛnt we fit dɛn.
• Sɔntɛnde dis kin ɛp bak fɔ no kwik if di kansa dɔn kam bak afta dɛn dɔn du di ɔpreshɔn.

Pan ɔl we dis we fɔ du tin stil de na di risach stej, ɔlman biliv se i go rili impɔtant tumara bambay fɔ mɛn di bɔdi kansa.

Sɔlv fɔ kansa tru nanoteknɔlɔji

Nanoteknɔlɔji na sayɛns we de yuz patikyula tin dɛn we tu smɔl fɔ si wit di yay. Dis na fayn ɛp fɔ mɛn kansa.

Imajin if yu kin kɛr wan paket go na di rayt adrɛs, lɛk kɔriɔ, bay we yu put di kemotɛrapi mɛrɛsin dɛn insay nanopartikul dɛn ɛn sɛn dɛn dairekt to di kansa sɛl? Na dat nanoteknɔlɔji de du. Di big bɛnifit we dis kin gɛt na dat di kemotɛrapi drɔgs kin pwɛl di kansa sɛl dɛn dairekt wan ɛn nɔ kin ambɔg di wɛlbɔdi tisu we de rawnd am. Dis kin ridyus di sayd ɛfɛkt dɛn bad bad wan ɛn i kin mek di tritmɛnt gɛt mɔ sakrifays.

Klinik Trial dɛn we dɛn kin du

Dɛn de du klinik trial ɔlsay na di wɔl fɔ tɛst nyu mɛrɛsin ɛn tritmɛnt fɔ bɔdi kansa. Di men gol fɔ dɛn trial ya na fɔ fɛn tritmɛnt dɛn we go wok fayn, we nɔ go gɛt bɔku sayd ɛfɛkt, ɛn we nɔ go mek di pɔsin we sik nɔ fil fayn .

Fɔ tek pat pan trial lɛk dis kin gi yu di chans fɔ tray nyu tritmɛnt ia bifo i hit di makit. Bɔt nɔto fɔ ɔlman. So i bɛtɛ fɔ tɔk to yu dɔktɔ bɔt if i fayn fɔ yu ɛn wetin de fayn ɛn bad.